These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22002075)

  • 1. Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients.
    Hendriksen KV; Jensen T; Oturai P; Feldt-Rasmussen B
    Diabetologia; 2012 Jan; 55(1):46-50. PubMed ID: 22002075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review.
    Frier BM; Russell-Jones D; Heise T
    Diabetes Obes Metab; 2013 Nov; 15(11):978-86. PubMed ID: 23551900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of insulin detemir and NPH insulin on body weight and appetite-regulating brain regions in human type 1 diabetes: a randomized controlled trial.
    van Golen LW; Veltman DJ; IJzerman RG; Deijen JB; Heijboer AC; Barkhof F; Drent ML; Diamant M
    PLoS One; 2014; 9(4):e94483. PubMed ID: 24739875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced weight gain with insulin detemir compared to NPH insulin is not explained by a reduction in hypoglycemia.
    Davies MJ; Derezinski T; Pedersen CB; Clauson P
    Diabetes Technol Ther; 2008 Aug; 10(4):273-7. PubMed ID: 18715200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis.
    Dejgaard A; Lynggaard H; Råstam J; Krogsgaard Thomsen M
    Diabetologia; 2009 Dec; 52(12):2507-12. PubMed ID: 19838665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes.
    Smeeton F; Shojaee Moradie F; Jones RH; Westergaard L; Haahr H; Umpleby AM; Russell-Jones DL
    Diabetologia; 2009 Nov; 52(11):2317-23. PubMed ID: 19707744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.
    Horvath K; Jeitler K; Berghold A; Ebrahim SH; Gratzer TW; Plank J; Kaiser T; Pieber TR; Siebenhofer A
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005613. PubMed ID: 17443605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparison of 24-hour urinary sodium, albumin, and protein excretion in chronic kidney disease patients with type 2 diabetes mellitus using insulin detemir or insulin glargine.
    Afsar B
    Clin Drug Investig; 2013 Oct; 33(10):773-8. PubMed ID: 23943142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral blood flow and glucose metabolism in appetite-related brain regions in type 1 diabetic patients after treatment with insulin detemir and NPH insulin: a randomized controlled crossover trial.
    van Golen LW; IJzerman RG; Huisman MC; Hensbergen JF; Hoogma RP; Drent ML; Lammertsma AA; Diamant M
    Diabetes Care; 2013 Dec; 36(12):4050-6. PubMed ID: 24130356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin detemir reduces weight gain as a result of reduced food intake in patients with type 1 diabetes.
    Zachariah S; Sheldon B; Shojaee-Moradie F; Jackson NC; Backhouse K; Johnsen S; Jones RH; Umpleby AM; Russell-Jones DL
    Diabetes Care; 2011 Jul; 34(7):1487-91. PubMed ID: 21593292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2).
    Wheeler MD; Barrientos-Perez M; Lo FS; Liang B; Lunsford A; Thórisdóttir Ó; Zuckerman-Levin N
    Eur J Pediatr; 2018 Oct; 177(10):1497-1503. PubMed ID: 30014302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of treatment with insulin detemir and NPH in women with gestational diabetes mellitus: glycemic control and pregnancy outcomes. A retrospective study.
    Kazakou P; Paschou SA; Mitropoulou M; Vasileiou V; Sarantopoulou V; Anastasiou E
    Hormones (Athens); 2023 Dec; 22(4):695-701. PubMed ID: 37775682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy.
    Hermansen K; Madsbad S; Perrild H; Kristensen A; Axelsen M
    Diabetes Care; 2001 Feb; 24(2):296-301. PubMed ID: 11213882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes.
    Herrera KM; Rosenn BM; Foroutan J; Bimson BE; Al Ibraheemi Z; Moshier EL; Brustman LE
    Am J Obstet Gynecol; 2015 Sep; 213(3):426.e1-7. PubMed ID: 26070699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of insulin detemir compared with NPH insulin in people with type 2 diabetes in Denmark, Finland, Norway, and Sweden.
    Ridderstråle M; Jensen MM; Gjesing RP; Niskanen L
    J Med Econ; 2013; 16(4):468-78. PubMed ID: 23384160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin detemir: a review of its use in the management of diabetes mellitus.
    Keating GM
    Drugs; 2012 Dec; 72(17):2255-87. PubMed ID: 23110609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.
    Heise T; Nosek L; Rønn BB; Endahl L; Heinemann L; Kapitza C; Draeger E
    Diabetes; 2004 Jun; 53(6):1614-20. PubMed ID: 15161770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial.
    Bartley PC; Bogoev M; Larsen J; Philotheou A
    Diabet Med; 2008 Apr; 25(4):442-9. PubMed ID: 18387078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is insulin detemir able to favor a lower variability in the action of injected insulin in diabetic subjects?
    Valensi P; Cosson E
    Diabetes Metab; 2005 Sep; 31(4 Pt 2):4S34-4S39. PubMed ID: 16389896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin analogs versus human insulin in type 2 diabetes.
    Migdalis IN
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S102-4. PubMed ID: 21864739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.